Rituximab in chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus.
J Neurol Sci
; 256(1-2): 100-2, 2007 May 15.
Article
en En
| MEDLINE
| ID: mdl-17382963
ABSTRACT
The authors report a 57-year-old patient with chronic inflammatory demyelinating polyneuropathy (CIDP) associated with diabetes mellitus (DM) who was treated successfully with rituximab. The B lymphocyte suppression using rituximab was followed 4 weeks later by neurological improvement and a stable disease course of over 10 months. We suggest that rituximab may be a treatment option in CIDP increasingly less responsive to intravenous immunoglobulin, particularly in patients with concurrent DM.
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Antirreumáticos
/
Polirradiculoneuropatía Crónica Inflamatoria Desmielinizante
/
Diabetes Mellitus
/
Anticuerpos Monoclonales
Tipo de estudio:
Risk_factors_studies
Límite:
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2007
Tipo del documento:
Article